您当前的位置:
首页 >
文章列表页 >
Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options
Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options
Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options
- Military Medical Research 2023年10卷第2期 页码:242-261
DOI: 10.1186/s40779-022-00422-y
移动端阅览
HTML全文
图( 4 ) 表( 0 )
参考文献
出版信息
数据统计
66
浏览量
19
下载量
0
CSCD
文章被引用时,请邮件提醒。
提交
工具集
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
相关文章
Expert consensus on the monitoring and treatment of sepsis-induced immunosuppression
Advancing our understanding of monocyte HLA-DR, S100A9, and the potential for individualized therapies in sepsis
Single-cell transcriptome profiling of sepsis identifies HLA-DRlowS100Ahigh monocytes with immunosuppressive function
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation
相关作者
Fei Pei
Ren-Qi Yao
Chao Ren
Soheyl Bahrami
Timothy R. Billiar
Irshad H. Chaudry
De-Chang Chen
Xu-Lin Chen
相关机构
Department of Critical Care Medicine, the First Affiliated Hospital of Sun Yat-Sen University
Translational Medicine Research Center, Medical Innovation Research Division and Fourth Medical Center of the Chinese PLA General Hospital
Department of Burn Surgery, the First Affiliated Hospital of Naval Medical University
Ludwig-Boltzmann Institute for Experimental and Clinical Traumatology
Department of Surgery, University of Pittsburgh Medical Center

